Novel Drugs Approved by the United States FDA in 2024
March 2026
in “
Korean Journal of Clinical Pharmacy
”
TLDR In 2024, the FDA approved 50 new drugs, including treatments for hair loss, anemia, high blood pressure, and Alzheimer's.
In 2024, the FDA approved 50 novel drugs, including deuruxolitinib for alopecia areata, which is significant for hair loss treatment. Other notable approvals include vadadustat for anemia in chronic kidney disease, aprocitentan for refractory hypertension, and donanemab for Alzheimer's disease. This review highlights the clinical pharmacology and therapeutic insights of these drugs to aid pharmacy education and clinical decision-making.
